Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakesh Rana

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JMIR Research Protocols|February 18, 2025
Effectiveness of Composite Ayurveda Regimen in a Black Box Design for the Management of Rheumatoid Arthritis: Protocol of a Single Arm, Community-Based StudyDeepa Makhija, Sunita Mata, Abha Sharma, et al.
Complementary Therapies in Medicine|February 12, 2022
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaHarbans Singh, Sumit Srivastava, Babita Yadav, et al.
JMIR Research Protocols|November 11, 2024
Effectiveness of Ayush Rasayana A and B on the Quality of Life of Older Adults: Protocol for a Cluster Randomized Controlled TrialPallavi Mundada, Deepa Makhija, Sunita Mata, et al.
Journal of Ayurveda and Integrative Medicine|January 15, 2021
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot studyManohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Ayu|December 15, 2021
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trialR Govind Reddy, Rajesh Vithal Gosavi, Babita Yadav, et al.
Complementary Therapies in Medicine|July 23, 2023
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trialHarbans Singh, Babita Yadav, Amit K Rai, et al.
Journal of Vector Borne Diseases|December 5, 2024
Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for the treatment of chronic inflammatory lymphedema, a double blind, placebo controlled, multicentric studyAchintya Mitra, Gurucharan Bhuyan, C Muralikrishna, et al.
Nanomedicine (London, England)|March 28, 2023
Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseasesSujata Maurya, Rashi Srivastava, Saniya Arfin, et al.
Journal of Ayurveda and Integrative Medicine|April 11, 2025
Evaluation of Yograj Guggulu, Ashwagandha Churna and Narayana Taila in management of Osteoarthritis Knee: A study in tribal dominant communityKalpana Kachare, Deepa Makhija, Abha Sharma, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JMIR Research Protocols|February 18, 2025
Effectiveness of Composite Ayurveda Regimen in a Black Box Design for the Management of Rheumatoid Arthritis: Protocol of a Single Arm, Community-Based StudyDeepa Makhija, Sunita Mata, Abha Sharma, et al.
Complementary Therapies in Medicine|February 12, 2022
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaHarbans Singh, Sumit Srivastava, Babita Yadav, et al.
JMIR Research Protocols|November 11, 2024
Effectiveness of Ayush Rasayana A and B on the Quality of Life of Older Adults: Protocol for a Cluster Randomized Controlled TrialPallavi Mundada, Deepa Makhija, Sunita Mata, et al.
Journal of Ayurveda and Integrative Medicine|January 15, 2021
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot studyManohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Ayu|December 15, 2021
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trialR Govind Reddy, Rajesh Vithal Gosavi, Babita Yadav, et al.
Complementary Therapies in Medicine|July 23, 2023
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trialHarbans Singh, Babita Yadav, Amit K Rai, et al.
Journal of Vector Borne Diseases|December 5, 2024
Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for the treatment of chronic inflammatory lymphedema, a double blind, placebo controlled, multicentric studyAchintya Mitra, Gurucharan Bhuyan, C Muralikrishna, et al.
Nanomedicine (London, England)|March 28, 2023
Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseasesSujata Maurya, Rashi Srivastava, Saniya Arfin, et al.
Journal of Ayurveda and Integrative Medicine|April 11, 2025
Evaluation of Yograj Guggulu, Ashwagandha Churna and Narayana Taila in management of Osteoarthritis Knee: A study in tribal dominant communityKalpana Kachare, Deepa Makhija, Abha Sharma, et al.
Pageof 3